HomeFileCoronary disease

Coronary disease

View Category

Chronic Coronary Syndromes

Variability of Coronary Physiology (FFR/iFR) in Diffuse Tandem Lesions

Physiology guided revascularization has been shown to improve clinical outcomes vs. conventional angiography. However, after percutaneous coronary...
Dr. Omar Tupayachi -
Learn More
Coronary disease

OCT Assessment of Bioresorbable Scaffold Performance across Different Types of Plaque

The development of bioresorbable magnesium scaffolds (RMS) has generated significant expectation in the field of percutaneous coronary...
Dr. Omar Tupayachi -
Learn More
Acute coronary syndromes

Early Discharge After STEMI: Clinical Benefit and Cost-Effectiveness?

Improvements in reperfusion strategies for ST-segment elevation myocardial infarction (STEMI) have transformed the prognosis for this condition....
Dr. Omar Tupayachi -
Learn More
Chronic Ischemic cardiopathy

Can Intense Exercise Modify the Coronary Atherosclerosis Profile?

While physical activity is a widely accepted recommendation for preventing cardiovascular disease, questions remain regarding the impact...
Dr. Juan Manuel Pérez -
Learn More
Chronic Coronary Syndromes

Polymer-Free vs. Biodegradable Polymer Stents: SORT OUT IX 5-Year Outcomes

In a constant strive to achieve life time management, interventional cardiologists focus on optimizing coronary scaffolds, which...
Dr. Omar Tupayachi -
Learn More
Chronic Coronary Syndromes

Chronic Stent Recoil and Its Long-Term Effects

The evolution of stent technology—including new scaffold designs, thinner struts, and more biocompatible polymers—has brought about an...
Dr. Omar Tupayachi -
Learn More
Acute coronary syndromes

PROSPECT II Substudy: Relationship Between Different Levels of hs-CRP and Vulnerable Plaque Characteristics in Patients with NSTEMI

Inflammation plays a key role in the onset and progression of atherosclerosis and has been linked to...
Dr. Andrés Rodríguez -
Learn More
Acute coronary syndromes

Aspirin vs. Clopidogrel Monotherapy After 1 Month of ACS: Subgroup Analysis Based on Bleeding Risk and MI Type

Current guidelines still recommend dual antiplatelet therapy (DAPT) for 12 months following percutaneous coronary intervention (PCI) as...
Dr. Andrés Rodríguez -
Learn More